Chipscreen Biosciences
Drug-discovery company developing small molecules for oncology, autoimmune and metabolic diseases.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Ovarian Cancer
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer PatientsPhase 3 · Recruiting · Colorectal Cancer
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypePhase 3 · Recruiting · Lymphoma, T-Cell, Peripheral
A Study of NWY001 in Subjects With Advanced Solid TumorsPhase 1 · Recruiting · Advanced Solid Tumor
A Study of CS23546 in Subjects With Advanced TumorsPhase 1 · Recruiting · Advanced Tumors
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque PsoriasisPhase 1 · Recruiting · Plaque Psoriasis
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/chipscreen-biosciences/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.